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Discrepancies between upper GI symptoms
described by those who have them and their
identification by conventional medical terminology:
a survey of sufferers in four countries
Robert C. Headinga, Edward C.M. Thomasb,*, Phil Sandyc, Gary Smithb, Ronnie Fassd and Pali S. Hungina
Objective The objective of this study was to develop a self-administered questionnaire for upper gastrointestinal (GI) symptoms
using lay vocabulary uninfluenced by established medical terminology or concepts and to conduct a survey of symptom
occurrence among sufferers in four countries.
Methods The questionnaire was designed by integrating information gained from the vocabulary used by 38
upper GI symptom sufferers. There was no medical input to its development. The questionnaire was then used, after
appropriate translation, in Brazil, Russia, the UK and the USA. Details of 10 659 symptom episodes were obtained from 2665
individuals.
Results Nine symptoms described in lay vocabulary were identified during questionnaire development. Of these, one
corresponded to regurgitation, whereas two that were distinguished by survey participants might both be interpreted as
heartburn. One chest symptom for which a corresponding medical term was uncertain occurred in ∼ 30% of the respondents.
Five different ‘stomach’ or abdominal symptoms were identified. The predominant symptom and the pattern of concurrent
symptoms often varied from one symptom episode to another. Use of the terms ‘heartburn’, ‘reflux’, ‘indigestion’ and ‘burning
stomach’ to describe symptoms varied between countries.
Conclusion Some common upper GI symptoms described by those who suffer them have no clear counterpart in
conventional medical terminology. Inadequacy of the conventional terminology in this respect deserves attention, first, to
characterize it fully, and thereafter to construct enquiry that delivers more precise symptom identification. Our results suggest
that improvement may require the use of vocabulary of individuals suffering the symptoms without imposing conformity with
established symptom concepts. Eur J Gastroenterol Hepatol 28:455–462
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Most studies on upper gastrointestinal (GI) symptom occur-
rence are founded on the use of questionnaires. Various
methodologies have been used to develop them, but patient
input into their development has become the norm [1–8]. For
example, the Glasgow Dyspepsia Questionnaire [1], the Global
Overall Symptom scale [2], the Leeds Dyspepsia Questionnaire
[3], the Nepean Dyspepsia Index [4], the Reflux Disease
Questionnaire [5], ReQuest [6], and the REFLUX ques-
tionnaire [7] have all been designed utilizing information
obtained from patients. Self-administered questionnaires have
been favoured in recent years, with the involvement of focus
groups to help formulate the wording of the questions such
that they will be readily understood by patients [4–7]. This
‘patient-friendly’ wording is then reconciled with established
medical terminology, which is the basis of subsequent analysis.
To our knowledge, no survey has yet used an upper GI
symptom questionnaire constructed using layperson-based
language without reference to the established medical symp-
tom vocabulary.
Our study aimed to create a self-administered ques-
tionnaire for upper GI symptoms using layperson voca-
bulary without imposition of medical terminology or
concepts, and to use it in a survey of symptom occurrence
among sufferers in four countries.
Methods
Survey content
The survey and an online diary were developed and under-
taken, and the responses were collated by two specialist market
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research companies (Winkle BV, Keizersgracht, Amsterdam,
The Netherlands and Msi-aci BV, Joop Geesinkweg,
Amsterdam, The Netherlands).
Lay market research agency screening identified partici-
pants (eight in Brazil and 10 each in Russia, the UK and the
USA) aged between 18 and 64 years who had experienced
upper GI symptoms within the previous 3 months. Moderators
then conducted a series of qualitative one on one interviews in
which they asked these participants to describe their symptoms
in their own words, describing both the physical sensation they
experienced and its location. Multiple symptoms, sometimes
concurrent, were described in many instances. All these
descriptions were then collated and used to draft questions in
lay language (i.e. without using any medical terminology) for
the questionnaire and diary. Symptoms that were infrequent
among the participants interviewed were not taken into con-
sideration for the questionnaire.
The questions were first drafted in English and then
translated by a professional translation agency into the
local languages. The drafts were then sent back to the
moderators who had conducted the interviews for review
and any revision necessary to ensure that the translations
accorded with their original interview findings.
Screening and extended survey
Members of a market research panel were invited by email
to complete the questionnaire entitled ‘New Survey about
Health Issues’. The invitees, aged between 18 and 64 years,
in Brazil, Russia, the UK and the USA were drawn at
random from the market research panel. Panel member-
ship required that the individual be responsible, either
mainly or jointly, for shopping for medicines/medications.
This initial screening survey consisted of a demographic
questionnaire and questions to establish whether the par-
ticipant had experienced any of the specified upper GI
symptoms in the appropriate part of the body within the
last 3 months (Fig. 1). Individuals answering positively
were allowed access to an extended survey, which asked
about the last symptom episode in more depth, including a
question about what term they would use to describe their
ailment to a doctor or a friend.
A target respondent sample size of 450 per country was
set. Allowing for a drop-out rate of 50% between the
survey and diary stages, the target was ∼900 per country
for the initial survey.
Online diary
Participants who entered the diary phase were emailed a link
each day for up to 6 weeks between June and August 2010.
They were asked to indicate whether they had experienced
any of the listed symptoms that day in the labelled areas of
their bodies (symptom locations shown in Fig. 1; see text,
Supplemental digital content 1, http://links.lww.com/EJGH/
A70 for the online diary questions). The participants were
then asked more detailed questions on up to seven symptom
episodes (occurrence of symptoms) experienced on different
days during the 6-week period. The information requested
included identification of the predominant (most intense)
symptom on each occasion, rating its severity as mild,
average or severe, and indicating its duration, timing and
location (see text, Supplemental digital content 1, http://
links.lww.com/EJGH/A70). Answers to other questions
about psychological and emotional responses to the symp-
toms, medications and any action taken in an attempt to
gain relief have not been reported in this paper.
Statistical analysis of symptoms
Data were analyzed using SAS software (SAS Institute Inc.,
Cary, North Carolina, USA) and descriptive statistics
compiled according to the following populations: (a) sur-
vey responders; (b) survey and diary responders; (c) survey
and diary responders with more than one diary episode; (d)
all episodes in diary. Analysis was carried out with all nine
symptoms as reported by responders and, subsequently,
with symptoms partly grouped according to medical ter-
minology. For this latter purpose, positive responses to
question 1 (Fig. 1) were considered to be regurgitation, to
question 3 to be heartburn and to questions 4, 5, 7, 8 and 9
to be dyspepsia. Owing to uncertainty about the appro-
priate medical terms for symptoms represented by ques-
tions 2 and 6, no conventional medical term was applied to
them, and they are abbreviated hereafter as ‘sharp rising
pain: food pipe’ and ‘blocked feeling: chest’, respectively.
The binomial outcomes collected at the participant level
were compared between sex and age group (<45 years,
≥45 years) using a χ2-test.
The ordinal outcomes collected at the participant level
were analyzed using a logistic regression model, with
country as a fixed effect. Pairwise comparisons between
countries were carried out from these models.
The binomial or ordinal outcomes collected per symp-
tom episode across online diary participants were analyzed
using logistic regression models with either sex, age group
(<45 years, ≥45 years) or country included as fixed effects
and participant as a random effect. Pairwise comparisons
between countries were carried out using these models.
Results
Survey and diary completion
The screening survey identified a total of 5158 participants
with the specified upper GI symptoms in the appropriate
part of the body within the previous 3 months. Of these,
2665 provided diary responses related to 10 659 symptom
episodes. Demographic data are presented in Table 1.
Incidence of symptoms as described in the online diary
Table 2 shows the symptoms reported by the participants.
‘Uncomfortably full/heavy stomach after a regular sized meal’
and ‘bitter or acidic taste in the back of the throat or mouth’
(regurgitation) were the most frequent; ‘burning sensation in
the middle of the abdomen’ was least frequently reported.
‘Blocked feeling or sensation that something is caught in the
chest’ and ‘bitter or acidic taste’ occurred with similar fre-
quencies in all countries. Some other symptoms such as
burning sensation in the chest and burning sensation in the
stomach showed statistically significant differences between
countries, but the relative frequencies of the nine symptoms
were broadly similar in all. Most symptoms were equally
frequent in male and female participants, but they were more
frequent in the older than in the younger age group.
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Predominant symptoms
Symptom predominance and severity
When the five symptoms comprising ‘dyspepsia’ (see Fig. 1)
were considered as one entity, it was the most commonly
reported predominant symptom, being identified as such by
2121 (79.6%) participants during at least one episode.
‘Bitter/acidic taste’ (regurgitation) was reported as the
predominant symptom at least once by 1158 (43.5%)
participants, ‘burning sensation: chest’ (heartburn) by 525
(19.7%), ‘blocked feeling: chest’ by 443 (16.6%) and ‘sharp
rising pain: food pipe’ by 385 (14.4%) participants.
The frequency with which each of the five symptoms was
reported as predominant varied by country (P≤0.0022; see
Figure, Supplemental digital content 2, http://links.lww.com/
EJGH/A71). Notable differences were observed for ‘blocked
feeling: chest’, which was most frequent in Russia (164,
20.1%) and least frequent in Brazil (60, 10.3%), and
‘burning sensation: chest’ had a higher prevalence in the UK
(187; 27.1%) and the USA (146, 25.3%) compared with
Brazil (78, 13.4%) and Russia (114, 14.0%).
Reported severity of the symptoms varied by country
(Fig. 2). Overall, the predominant symptoms were mostly
classed as ‘average’ in severity (51.2%); 38% were classed
‘mild’ and 10.9% as ‘severe’. Fewer participants in Brazil
reported their predominant symptom as severe and more
described it as mild compared with the USA, UK and
Russian participants (P<0.0001 for all comparisons).
The predominant symptom varied in 67% of those who
reported more than one symptom episode. Two different
predominant symptoms were reported on different occa-
sions by 894 (44%) participants, three different symptoms
by 359 (18%), four different symptoms by 101 (5%) and
five different predominant symptoms by 13 (0.6%) parti-
cipants (Fig. 3).
Burning sensation or burning pain in the stomach
Uncomfortably full/heavy stomach after a regular-sized meal
Participants were eligilble to continue if any of the symptoms
numbered 1−5 were experienced in locations A, C, or F or any
of the symptoms 6−9 were experienced in locations F, H, I or J.
Eligible participants were then invited to begin recording their
upper GI symptoms in an online diary.
Dull ache or discomfort (nonburning) in the stomach
Dull ache or discomfort (nonburning) in the middle of the
abdomen (above the belly button but not in the chest)
Blocked feeling or sensation that something is caught − in the
chest
Burning sensation or burning pain in the middle of the
abdomen (above the belly button but not in the chest)
Burning sensation or burning pain in the chest
(not related to heart problems)
Sharp rising pain in the food pipe
Bitter or acidic taste in the (back of) the throat or mouth Regurgitation1
2
3
4
5
6
7
8
9
Question
number Medical terminology
∗
Heartburn
Dyspepsia
Dyspepsia
Dyspepsia
Dyspepsia
Dyspepsia
A
B C D
E F G
H I J
Not attributed
Not attributed
Fig. 1. Eligibility criteria. Participants were asked whether they had experienced any of these symptoms in the past 3 months. If so, they were asked ‘Where in
your body did you feel this symptom was located?’ and to respond with reference to the diagram. *See text for explanation of proposed medical terminology.
GI, gastrointestinal.
Table 1. Demographic data of the eligible respondents of the screening
survey and diary completers
Screening survey Online diary
Total number invited to take part 93 686 –
Total number who participated 12 457 –
Total number of eligible participants [n (%)] 5158 (100) 2665 (100)
Sex [n (%)]
Male 1770 (34.4) 864 (32.4)
Female 3388 (65.7) 1801 (67.6)
Age group (years) [n (%)]
18–24 494 (9.6) 242 (9.1)
25–34 1264 (24.5) 698 (26.2)
35–44 1105 (21.4) 591 (22.2)
45–54 1149 (22.3) 611 (22.9)
55–64 1146 (22.2) 523 (19.6)
<45 2863 (55.5) 1531 (57.4)
≥45 2295 (44.5) 1134 (42.6)
Country [n (%)]
Brazil 944 (18.3) 583 (21.9)
Russia 1431 (27.7) 814 (30.5)
United Kingdom (UK) 1429 (27.7) 691 (25.9)
United States (US) 1354 (26.3) 577 (21.7)
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Predominant symptom timing
Participants also recorded the time of day when their
predominant symptom was at its strongest (Fig. 4a).
Overall, ‘bitter/acidic taste’ was most commonly reported
in the morning upon waking (32.4%), whereas post-
prandial periods were particularly associated with the
occurrence of other symptoms. ‘Burning sensation: chest’
was most commonly reported in the afternoon after lunch
(20.1%) and at other times in the afternoon (20.5%).
‘Sharp rising pain: food pipe’ was most commonly repor-
ted after lunch (18.5%) and dinner (19.0%), with a
combined after lunch/dinner prevalence of 37.6%.
‘Dyspepsia’ was most common after lunch (23.8%) and
dinner (23.2%), with a combined after lunch/dinner pre-
valence of 47.0%.
An effect of country on the prevalence of ‘bitter/acidic
taste’ in the morning was observed (P<0.0001), with
Brazil and Russia reporting an approximately two-fold
greater prevalence in this symptom at this time point (41.8
and 44.7%, respectively) than the USA and UK (21.5 and
21.0%, respectively). Pairwise comparisons for the USA or
UK versus Brazil or Russia were all highly significant
(P<0.0001). The prevalence of ‘sharp rising pain: food
pipe’ after lunch/dinner also varied by country, with
Russia having a significantly lower prevalence (23.7%)
compared with the USA (37.0%, P=0.0296) and the UK
(45.1%, P=0.0008), although not significant when com-
pared with Brazil (37.3%, P= 0.0554).
Predominant symptom duration
The reported durations of the predominant symptoms are
shown in Fig. 4b. ‘Bitter or acidic taste in the back of the
throat or mouth’, ‘sharp rising pain in the food pipe’ and
‘burning sensation or burning pain in the chest’ most
commonly lasted between 15min and 1 h (28.6, 26.6 and
26.0%, respectively). ‘Blocked feeling or sensation that
something is caught in the chest’ and ‘dyspepsia’ most
commonly lasted between 1 and 2 h (25.3 and 28.7%,
respectively).
Table 2. Incidence of online diary reported symptoms
Bitter/acidic
taste
[N (%)]
Sharp rising
pain: food pipe
[N (%)]
Burning
sensation:
chest
[N (%)]
Burning
sensation:
abdomen
[N (%)]
Burning
sensation:
stomach
[N (%)]
Blocked
feeling: chest
[N (%)]
Dull ache:
abdomen
[N (%)]
Dull ache:
stomach
[N (%)]
Heavy
stomach
[N (%)]
All 1490 (55.9) 752 (28.2) 892 (33.5) 728 (27.3) 816 (30.6) 783 (29.4) 994 (37.3) 1245 (46.7) 1613 (60.5)
Brazil 312 (53.5) 150 (25.7) 192 (32.9) 214 (36.7) 303 (52.0) 158 (27.1) 200 (34.3) 256 (43.9) 364 (62.4)
Russia 452 (55.5) 172 (21.1) 180 (22.1) 163 (20.0) 186 (22.9) 234 (28.7) 279 (34.3) 371 (45.6) 509 (62.5)
UK 387 (56.0) 245 (35.5) 275 (39.8) 159 (23.0) 137 (19.8) 223 (32.3) 268 (38.8) 350 (50.7) 414 (59.9)
US 339 (58.8) 185 (32.1) 245 (42.5) 192 (33.3) 190 (32.9) 168 (29.1) 247 (42.8) 268 (46.4) 326 (56.5)
Male 481 (55.7) 237 (27.4) 291 (33.7) 245 (28.4) 284 (32.9) 253 (29.3) 283 (32.8) 365 (42.2) 521 (60.3)
Female 1009 (56.0) 515 (28.6) 601 (33.4) 483 (26.8) 532 (29.5) 530 (29.4) 711 (39.5) 880 (48.9) 1092 (60.6)
<45 years 813 (53.1) 374 (24.4) 440 (28.7) 370 (24.2) 448 (29.3) 408 (26.6) 517 (33.8) 711 (46.4) 938 (61.3)
≥45 years 677 (59.7) 378 (33.3) 452 (39.9) 358 (31.6) 368 (32.5) 375 (33.1) 477 (42.1) 534 (47.1) 675 (59.5)
N, number of respondents; %, percentage who answered ‘yes’ for each question.
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Fig. 2. Severity of predominant symptom by country. P-values relate to variability of predominant symptoms across episodes reported by individual
participants (ordinal logistic regression with random participant effect).
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Overall, there were differences in the duration of pre-
dominant symptoms between all countries except the USA
and the UK (P<0.0001). Sex also demonstrated differences
(P<0.0001). There were no differences between age groups
(see Figures, Supplemental digital content 3, http://links.lww.
com/EJGH/A72, Supplemental digital content 4, http://links.
lww.com/EJGH/A73, and Supplemental digital content 5,
http://links.lww.com/EJGH/A74 for duration of pre-
dominant symptoms by country, age and sex, respectively).
Symptom concurrence
Across all episodes, multiple symptoms were reported on
28% of 10 603 occasions (Fig. 5). The discrepancy with the
10 659 symptom occasions shown in Fig. 2 arose from failure
to complete Section A of the diary (See text, Supplemental
digital content 1, http://links.lww.com/EJGH/A70) on 56
occasions. Dyspepsia accounted for most instances in which a
single symptom was reported (45% of all episodes), with
‘bitter or acidic taste in the throat or mouth’, ‘blocked feeling
or sensation that something is caught in the chest’, ‘burning
sensation or burning pain in the chest’ and ‘sharp rising pain
in the food pipe’ being the single symptom in 15.6, 3.9, 5.3
and 2.5% of episodes, respectively. Overall, two concurrent
symptoms were reported on 17.2% of occasions and the rates
of simultaneously suffering three, four and five concurrent
symptoms were 5.6, 2.0 and 2.9%, respectively (Fig. 5).
Particular attention was paid to the sharp rising pain in
the food pipe and the burning sensation or pain in the
chest in relation to the question of whether one or both
should be considered to correspond to heartburn. There
were 1975 occasions on which respondents reported
experiencing either the sharp rising pain in the food pipe or
the burning sensation or pain in the chest and a further
659 occasions (in 348 individuals) on which the two were
reported concurrently (Fig. 5). In addition to the occasions
on which the two symptoms occurred concurrently, 58%
of these individuals reported other occasions on which
they experienced either the sharp rising pain in the food
pipe or the burning sensation or pain in the chest
exclusively.
Correlation of patient language with symptom experience
The screening survey asked participants what term they
would use to describe their ailment. A high proportion
(544; 56.8%) of people from Russia, who experienced
‘bitter or acidic taste in the back of the throat or mouth’,
called it ‘heartburn’, with only 145 (15.2%) describing
their symptom as reflux/acid reflux. ‘Heartburn’ was also
the most common term used to describe bitter/acidic taste
in Brazil (238; 38.0%) compared with reflux/acid reflux,
preferred by 187 (29.9%) of subjects. Interestingly, 92
(14.7%) participants in Brazil described ‘bitter/acidic taste’
as ‘burning stomach’, compared with 1.9% of respondents
across the other countries. By contrast, reflux/acid reflux
was the most common descriptor for the bitter/acidic taste
in the back of the throat or mouth in the USA and the UK
(448, 52.6% and 431, 48.4%, respectively).
The majority of participants in the UK and the USA
called their burning sensation in the chest ‘heartburn’ (397,
52.4% and 474, 51.9%, respectively). However, only 95
(22.1%) and 176 (29.1%) participants in Brazil and Russia
called this symptom heartburn; it was more commonly
described as ‘burning stomach’ (89, 20.7%) in Brazil,
‘indigestion’ (98, 16.2%) in Russia or ‘other’ (111, 25.9%
Brazil and 105, 17.4% Russia). The term ‘indigestion’ was
also used for ‘burning sensation in the chest’ by 263
(28.8%) UK participants.
Discussion
Uncertainty about translating a patient’s description of
symptoms into established medical terminology is familiar to
many physicians, who acknowledge that conventional ter-
minology may not capture some aspects of symptom per-
ception that patients describe. Nevertheless, we are not aware
of any previous attempt at systematic creation of an upper GI
symptom questionnaire from sufferers’ own vocabulary
without reference to conventional medical concepts or ter-
minology. Our survey results describe the occurrence and
patterns of upper GI symptoms in 10 659 symptom episodes.
Matching the lay vocabulary of our questionnaire with
medical terminology revealed substantial disconnect.
Whereas ‘bitter or acidic taste in the back of the throat or
mouth’ may be interpreted as ‘regurgitation’, not least
because it was prominent on wakening in the morning [9],
equating ‘burning sensation or burning pain in the chest’
with heartburn implies that heartburn occurred only about
two-thirds as often as regurgitation in this population.
Burning chest pain or discomfort is widely taken to be a
description of heartburn, although Carlsson et al. [10]
advocated a definition in which the moving quality of the
feeling was recognized (a burning feeling rising from the
stomach or lower chest up towards the neck) and asserted
that this served to identify heartburn responsive to acid
suppressing medication. If ‘burning sensation or burning
pain in the chest’ and ‘sharp rising pain in the food pipe’
are considered to be alternative descriptions of heartburn,
combining the two implies that heartburn occurred more
frequently than regurgitation among our respondents.
However, the fact that 58% of individuals who reported
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Fig. 3. Predominant symptoms reported by respondents across all their
symptom episodes.
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having the two symptoms concurrently on some occasions
also reported having one without the other on other
occasions implies they are not simply alternative descrip-
tions of the same sensation. Consequently, use of the term
‘heartburn’ to denote both does not accurately represent
the symptoms being recognized by sufferers.
The symptom ‘blocked feeling or sensation that some-
thing is caught in the chest’ is also problematic. At first, it
might be thought to correspond to dysphagia, but sufferers
commonly reported a duration of 1–2 h, which seemingly
points against a direct relationship with swallowing. No
specific enquiry about swallowing was incorporated in the
questionnaire, and the online methodology of this study
did not allow further interrogation to characterize the
nature of the symptom further. Nevertheless, ‘blocked
feeling or sensation that something is caught in the chest’
was reported in almost one-third of respondents in all four
countries and, of course, was derived from the original
interviews with those experiencing the symptom. It is
therefore hard to refute that this wording describes a
sensation experienced by a significant proportion of indi-
viduals, but we cannot propose an obvious medical
counterpart.
Unsurprisingly, dyspepsia was the most common
symptom reported in all countries when the five symptoms
perceived in the ‘stomach’ or abdomen were grouped
together. Our results add to the existing evidence of
overlap between reflux and dyspepsia symptoms [11–13],
with 28% of respondents experiencing at least two
symptoms concurrently on any one occasion. This corre-
sponds closely to the findings of a community survey in
which coexisting dyspepsia and reflux symptoms occurred
in 24% of those reporting symptoms [12]. The overlap
between reflux disease and dyspepsia and whether to
consider them as a single entity [14] are key areas of debate
that are highly relevant to the challenge of accurate clinical
diagnosis.
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It is obvious that use of the single term ‘dyspepsia’ does
not respect the fact that our study participants were
describing five ‘stomach’ and abdominal symptoms that
they considered could be distinguished. Such conflation of
symptoms itself raises potential problems for precision of
diagnosis and choice of treatment. Acknowledging this, the
Rome III classification of functional dyspepsia refined
earlier definitions by introducing a distinction between
postprandial distress and epigastric pain syndromes. A
form of enquiry to identify the former has been proposed
[15], but these two variants of functional dyspepsia often
occur concurrently, prompting some to suggest that this
classification is inherently unsatisfactory [16]. However,
better identification of symptoms gained from more
detailed enquiry may be helpful [17,18]. In addition,
‘heartburn’ is said to occur commonly in individuals with
functional dyspepsia [14]. Our results have shown that
besides using the word ‘dyspepsia’ to describe five different
symptoms, the single word ‘heartburn’ cannot properly
represent both ‘sharp rising pain in the food pipe’ and
‘burning sensation or pain in the chest’. Thus, neither
dyspepsia nor heartburn is a precise term. Greater preci-
sion is required for both if diagnosis and classification of
upper GI disorders are to be improved.
Another aspect of our results with potential relevance to
clinical practice is the observation that two-thirds of par-
ticipants reported different predominant symptoms on
different occasions. To our knowledge, the magnitude of
this variability has not been demonstrated previously.
Some years ago, it was reported that a diagnosis of reflux
disease was likely to be correct if heartburn or regurgita-
tion was a clearly predominant symptom [19]. Subsequent
consensus statements pointed out that although pre-
dominant heartburn was thought to permit a diagnosis of
gastro-oesophageal reflux disease in 75–80% of patients,
this belief was based on clinical opinion rather than further
evidence [20,21]. More recently, guidelines have simply
advised that ‘typical symptoms of heartburn and regur-
gitation’ justify a presumptive gastro-oesophageal reflux
disease diagnosis [22]. Our findings show that in many
participants both the predominant symptom and the pat-
tern of concurrent symptoms vary from one symptom
episode to the next. Only one-third of individuals had one
symptom that was consistently predominant.
Apart from ‘bitter or acidic taste in the back of the
throat or mouth’, which was most common on waking up
in the morning, the majority of predominant symptoms
occurred mainly after meals. The pattern of predominant
nocturnal symptoms differed from that of daytime symp-
toms. The prevalence of nocturnal symptoms in our par-
ticipants was low compared with some reports [23],
although not all investigators found nocturnal symptoms
to be common [24]. Our results were almost certainly
influenced by inclusion of individuals with relatively mild
symptoms, and it is also possible that our questionnaire
did not reliably identify symptoms occurring during the
‘recumbent awake’ period, said to be especially important
in reflux disease [25].
National differences in the medical terms that partici-
pants thought to be appropriate to describe their symp-
toms were evident in our results. Most notably, the
symptom identified in all four countries as ‘bitter or acidic
taste in the back of the throat or mouth’ was termed
‘heartburn’ by many Russian participants and some
Brazilian participants, whereas in the USA and UK, it was
mostly termed ‘reflux’. A ‘burning sensation in the chest’
was considered by many participants in the UK and USA
to be heartburn, but it was less certainly identified as such
in Brazil and Russia. It seems inevitable that national dif-
ferences in vocabulary and symptom interpretation will, to
some degree, extend to physicians. Thus, although trans-
lation of basic medical terms such as heartburn, reflux and
regurgitation into different languages may be straightfor-
ward, the words may have different nuanced meanings in
different countries. Such differences have received little
attention in formal studies, but it is apparent that linguistic
and cultural factors will influence a patient’s under-
standing of his/her symptoms.
The use of market research panels does not allow direct
comparison with studies of unselected populations or with
patients consulting physicians. Moreover, the low thresh-
old of symptom frequency needed to enter our study may
also mean that the findings will differ from those reported
in many publications. However, difficulty in matching
some patients’ descriptions of their symptoms with the
conventional medical vocabulary is recognized by most
clinicians. When developing questionnaires for self-
administration, this potential difficulty has usually been
addressed by devising symptom enquiry in a manner that
aims to optimize identification of the medically recognized
symptoms [4–7,26,27]. Typically, patients are provided
with symptom descriptions, sometimes supported by word
pictures, and it is assumed that the established medical
vocabulary can properly represent the patients’ symptoms.
Any suggestion that the established upper GI symptom
terminology is flawed may be unsettling for physicians, not
least because it may introduce uncertainty into clinical
practice. However, our findings serve to endorse the well-
accepted clinical principles of listening carefully to patients’
own descriptions of their symptoms and avoidance of
putting words into their mouths. The findings also raise
some important questions that need direct study. For exam-
ple, does the conventional concept of heartburn actually
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embrace two symptoms (‘burning sensation or burning pain
in the chest’ and ‘sharp rising pain in the food pipe’) that
individuals responding to our questionnaire were seemingly
able to distinguish? If these are different symptoms, how
should each be interpreted? Likewise, should the symptom
‘blocked feeling or sensation that something is caught in the
chest’ identified by some of the study participants be con-
sidered dysphagia only if impaired swallowing is also per-
ceived? If there is no swallowing impairment, what should
this symptom be called and how should it be interpreted?
Our survey questionnaire was not designed as a tool for
clinical practice, nor was it designed to measure symptom
burden. No suggestion has been made that it would be
suitable for either purpose. Rather, the study has demon-
strated that the established medical terminology does not
identify some commonly occurring upper GI symptoms
that sufferers recognize when described using vocabulary
generated by fellow sufferers. Symptom descriptions based
on the vocabulary of individuals who suffer them merit
closer attention with a view to characterizing upper GI
symptoms more precisely.
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